Safety of transcatheter arterial chemoembolization for hepatocellular carcinoma in older adults aged ≥ 85 years: A single‐institution retrospective preliminary study

Documenti analoghi

• No lipiodol, no beads—another transcatheter arterial chemoembolization (TACE) with fine cisplatin powder and porous gelatin particles for TACE‐naïve, multifocal, up‐to‐seven out hepatocellular carcinoma
  di: Rui Sato, et al.
  Pubblicazione: (2024)
• Distinct gut microbiota alterations in patients with early‐stage and advanced‐stage hepatocellular carcinoma
  di: Ming‐Chao Tsai, et al.
  Pubblicazione: (2024)
• Decreased incidence of hepatocellular carcinoma in non‐cirrhotic and low‐viral‐load chronic hepatitis B patients treated with nucleotide/nucleoside analogs
  di: Tyng‐Yuan Jang, et al.
  Pubblicazione: (2025)
• STAT3 mediates cancer stem‐like tumorsphere formation and PD‐L1 expression to contribute radioresistance in HBV‐positive hepatocellular carcinoma
  di: Ai‐Sheng Ho, et al.
  Pubblicazione: (2024)
• Adenoma detection rate of screening colonoscopy among age 40–75 years: Implications for lowering the age for colorectal cancer screening
  di: Tsan‐Hsuan Chang, et al.
  Pubblicazione: (2024)